TradingMarkets’ 12 Stocks You Need To Know About Today
Disney (DIS)
beat by a penny; profits rose 24%; revenue was $7.54 billion, up 8% from a
year ago. CFO Tom Staggs said the company expects double-digit growth for the
next few years.
Oracle
(
ORCL |
Quote |
Chart |
News |
PowerRating) will report tender
offer results for PeopleSoft after 1 am ET Saturday.
Drug stocks will be in focus after a US health
official said drugs manufactured by Pfizer
(
PFE |
Quote |
Chart |
News |
PowerRating) and Abbott
(
ABT |
Quote |
Chart |
News |
PowerRating)
needed closer scrutiny. Also, safety concerns were raised on Astrazeneca’s
(
AZN |
Quote |
Chart |
News |
PowerRating) Crestor and GlaxoSmithKline’s
(
GSK |
Quote |
Chart |
News |
PowerRating) Serevent.
Genentech
(
DNA |
Quote |
Chart |
News |
PowerRating) and OSI
Pharmaceuticals
(
OSIP |
Quote |
Chart |
News |
PowerRating) said that its lung cancer drug Tarceva received
FDA approval. The drug is a competitor to Astrazeneca’s Iressa.
Autodesk (ADSK) beat, gave an optimistic outlook and announced a 2:1 stock split.
Sirius
(
SIRI |
Quote |
Chart |
News |
PowerRating) named former Viacom chief
Mel Karmazin, as CEO.
Novell
(
NOVL |
Quote |
Chart |
News |
PowerRating) beat by a penny, and a
Q3 profit compared to a year earlier loss.
Today is November options expiration.